Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark GenomeJACC. Basic to translational science, 2023-12, Vol.8 (12), p.1595-1598 [Peer Reviewed Journal]2023 The Authors. ;2023 The Authors 2023 ;ISSN: 2452-302X ;EISSN: 2452-302X ;DOI: 10.1016/j.jacbts.2023.09.006 ;PMID: 38205345Full text available |
|
2 |
Material Type: Article
|
AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytesMolecular therapy, 2022-12, Vol.30 (12), p.3601-3618 [Peer Reviewed Journal]2022 The Author(s) ;Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2022.07.003 ;PMID: 35810332Full text available |
|
3 |
Material Type: Patent
|
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHYDigital Resources/Online E-Resources |
|
4 |
Material Type: Patent
|
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHYDigital Resources/Online E-Resources |
|
5 |
Material Type: Patent
|
LncRNAs for therapy and diagnosis of cardiac hypertrophyDigital Resources/Online E-Resources |
|
6 |
Material Type: Patent
|
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHYDigital Resources/Online E-Resources |
|
7 |
Material Type: Patent
|
lncARNs para el tratamiento y el diagnóstico de la hipertrofia cardíacaDigital Resources/Online E-Resources |
|
8 |
Material Type: Patent
|
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHYDigital Resources/Online E-Resources |
|
9 |
Material Type: Patent
|
LNCRNAS til terapi og diagnose af hjertehypertrofiDigital Resources/Online E-Resources |
|
10 |
Material Type: Patent
|
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHYDigital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Abstract 114: Safety And Efficacy Of CDR132L, A Novel Antisense Therapeutic Which Targets MicroRNA-132 In Heart Failure PatientsCirculation research, 2021-09, Vol.129 (Suppl_1) [Peer Reviewed Journal]ISSN: 0009-7330 ;EISSN: 1524-4571 ;DOI: 10.1161/res.129.suppl_1.114Full text available |
|
12 |
Material Type: Article
|
ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related CardiomyopathyCirculation. Heart failure, 2021-07, Vol.14 (7), p.e006898-e006898 [Peer Reviewed Journal]ISSN: 1941-3289 ;EISSN: 1941-3297 ;DOI: 10.1161/CIRCHEARTFAILURE.120.006898 ;PMID: 34247489Full text available |
|
13 |
Material Type: Article
|
AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic ConstrictionJournal of the American College of Cardiology, 2021-06, Vol.77 (23), p.2923-2935 [Peer Reviewed Journal]Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.04.028 ;PMID: 34112319Full text available |
|
14 |
Material Type: Article
|
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failureEuropean heart journal, 2021-01, Vol.42 (2), p.192-201 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa791 ;PMID: 33089304Full text available |
|
15 |
Material Type: Article
|
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled studyEuropean heart journal, 2021-01, Vol.42 (2), p.178-188 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa898 ;PMID: 33245749Full text available |
|
16 |
Material Type: Article
|
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophyEuropean heart journal, 2020-09, Vol.41 (36), p.3462-3474 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa519 ;PMID: 32657324Full text available |
|
17 |
Material Type: Article
|
The roles of miRNA, lncRNA and circRNA in the development of osteoporosisBiological research, 2020-09, Vol.53 (1), p.1-40, Article 40 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 0717-6287 ;ISSN: 0716-9760 ;EISSN: 0717-6287 ;DOI: 10.1186/s40659-020-00309-z ;PMID: 32938500Full text available |
|
18 |
Material Type: Patent
|
LNCRNAS FOR THERAPY AND DIAGNOSIS OF CARDIAC HYPERTROPHYDigital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Preclinical development of a miR-132 inhibitor for heart failure treatmentNature communications, 2020-01, Vol.11 (1), p.633-10, Article 633 [Peer Reviewed Journal]This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-14349-2 ;PMID: 32005803Full text available |
|
20 |
Material Type: Article
|
miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung InjuryInternational journal of molecular sciences, 2020-01, Vol.21 (3), p.822 [Peer Reviewed Journal]2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21030822 ;PMID: 32012801Full text available |